Access cutting-edge myelofibrosis treatment through this clinical trial at a research site in Middletown. Study-provided care at no cost to qualified participants.
Access myelofibrosis specialists in Middletown at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myelofibrosis treatment provided free
The researchers are doing this study to find out whether the combination of ruxolitinib and ulixertinib is a safe and effective treatment for people with myelofibrosis. The researchers will test different doses of ulixertinib to find the highest dose that causes few or mild side effects in participants when given in combination with ruxolitinib.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this myelofibrosis clinical trial in Middletown, NJ
If you're searching for myelofibrosis treatment options in Middletown, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Middletown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myelofibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.